Zhang H, et al. – This multi–center, randomized controlled trial aimed to determine the impact of a pulmonary daoyin (PD) program in enhancing activity tolerance, patient–reported outcomes and satisfaction with the effectiveness on patients with chronic obstructive pulmonary disease (COPD). The authors concluded that the PD program was able to improve the activity tolerance level and satisfaction of COPD patients because of its effectiveness.